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The copy number variant involving part of the a7
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The a7 nicotinic acetylcholine receptor gene (CHRNA7) is located at 15q13–q14 in a region that is strongly
linked to the P50 sensory gating deficit, an endophenotype of schizophrenia and bipolar disorder. Part of
the gene is a copy number variant, due to a duplication of exons 5–10 and 30 sequence in CHRFAM7A,
which is present in many but not all humans. Maps of this region show that the two genes are in opposite
orientation in the individual mainly represented in the public access human DNA sequence database
(Build 36), suggesting that an inversion had occurred since the duplication. We have used fluorescent in situ
hybridization to investigate this putative inversion. Analysis of interphase chromosomes in 12 individuals
confirms the occurrence of an inversion and indicates that CHRFAM7A exists in both orientations with similar
frequency. We showed that the 2 bp deletion polymorphism in exon 6 of CHRFAM7A is in strong linkage
disequilibrium with the inversion polymorphism (r2¼0.82, CI 0.53–1.00, P¼0.00003), which can therefore be
used as a surrogate marker. Previous associations of endophenotypes of schizophrenia with the 2 bp deletion
might therefore be due to the orientation of the duplicon containing CHRFAM7A.
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Introduction
The a7 nicotinic acetylcholine receptor gene (CHRNA7)
is located at 15q13–q14, a region strongly linked to the
P50 sensory gating deficit, an endophenotype of schizo-
phrenia1,2 and bipolar disorder.3,4 The peak LOD score
(5.3) occurs at a marker in CHRNA7, with linkage also
supported by pharmacological evidence.5 Attempts to
demonstrate linkage of this region to either schizophrenia
or bipolar disorder have had mixed results, with one study
showing linkage to bipolar disorder6 and several
studies showing only weak evidence for linkage to schizo-
phrenia.1,2,7,8 There is also evidence for association of
CHRNA7 with schizophrenia and bipolar disorder.9
Together, these results suggest that P50 may be modulated
by variant(s) in the CHRNA7 region as one of many genetic
defects that increases susceptibility to the major psychoses.
This region has also been linked to two idiopathic
epilepsies.10,11
Genetic analysis of 15q13–q14 is complicated by a large
duplication of part of CHRNA7.12 We have previously
examined the sequence relationships of this and other
duplications in this region and showed that the partial
duplication of CHRNA7 (CHRFAM7A) is a hybrid of
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CHRNA7 and an unrelated sequence FAM7A, of which
there are several copies.13 Both FAM7A and CHRFAM7A are
transcribed, but translation is uncertain.
Our map of 15q13–q1413 (Figure 1, bottom) showed that
CHRNA7 and CHRFAM7A are in opposite orientations in
the DNA sequence database (Build 36), which is mostly
represented by the RP11 library. This suggests that an
inversion of CHRFAM7A may have taken place after the
partial duplication that generated it.13 Later assemblies of
the human sequence (NT_010194), after earlier incorrect
assemblies, support this map. There is now a continuous
tiling path of clones between the two ends of the map,
confirming our finding that CHRNA7 and CHRFAM7A are
in opposite orientation in the RP11 individual.14
The partial duplication of CHRNA7 is a recent event
unique to humans, with only CHRNA7 and not CHRFAM7A
in other higher primates.15 Chromosomes both with and
without CHRFAM7A have been identified in several human
populations, indicating a copy number variant (CNV) with
respect to the duplicated part common to CHRNA7 and
CHRFAM7A. We have recently shown association between
this CNV and the major psychoses.16 This study found
that the homozygous CHRFAM7A null genotype was rare,
but the heterozygote occurred in 24% of psychosis
patients compared to 16% of controls (P¼0.04). We have
deduced the likely structure of chromosomes with this
null CHRFAM7A allele,14 which may represent a persisting
ancestral chromosome. Other more recent ancestral
Figure 1 Model for generation of the duplicon containing CHRFAM7A. Homologous segments are indicated by the same letters, with positions and
orientation of genes CHRNA7, CHRFAM7A and FAM7A shown below. In the model, two minor variants of the ancestral structure Ia (structures Ib and Ic)
undergo a duplication mediated by non-allelic homologous recombination (NAHR) at the direct repeats QRAZRM to generate an intermediate
structure, which undergoes non-homologous deletion to bring segment A adjacent to segment H in structure IIa. (See Supplementary Figure 2 for
alternative scheme in which structure IIa is generated from structures Ib and Ic in one step.) Inversion of segments HSRZ (in the CHRFAM7A duplicon)
needs to occur to produce the RP11 structure (structure IIb), with deletion of the most telomeric segments AZ occurring here or at an earlier step, both
occurring by NAHR. Approximate sizes and positions of the three fluorescent probes are shown above appropriate segments for structures IIa and IIb
(yellow, RP11-143J24; green, 13H18; red, 30H17). Positions of duplicons associated with CHRNA7 and CHRFAM7A and the breakpoints 4 and 5 (BP4
and 5), involved in inv dup (15) supernumerary marker chromosomes are shown below structure IIb.
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chromosomal structures predating the putative inversion
may also exist. In this paper, we demonstrate examples of
both pre- and post-inversion forms showing that such an
ancestral chromosome does persist and is very common.
Materials and methods
Identification of chimpanzee clones
Orthologous Pan troglodytes clones were identified using
BLASTN against fully sequenced clones (nr/nt) or against
genome survey sequences (gss) for clone end sequences,
and aligned with human contig NT_010194.16 using Blast
Two Sequences (www.ncbi.nlm.nih.gov/blast/Blast.cgi).
Sample
A total of 12 lithium heparin-treated fresh blood samples
were from the First Onset of Psychosis Study (Institute of
Psychiatry). Clinical data are summarized in Table 1.
DNA preparation and assays
DNA was prepared from 1 ml of blood using the QIAamp
DNA blood midi kit (Qiagen). The 2 bp deletion genotype
and copy number of CHRFAM7A were determined as
described previously.16
Probe selection for fluorescence in situ hybridization
BAC clone (RP11-143J24, AC087455; http://bacpac.chori.org/)
was selected as fluorescence in situ hybridization
(FISH) probe for segment B. For duplicated segments S and
H (Figure 1), cosmid clones were used as probes because
their smaller size (approximately 40 kb) enabled more
precise targeting. PCR primers GACCTAGATCCACAGTA
AG, CAGGTGGAGATTCCAAGAGC (segment S, from RP13-
395E19, AC139426), TATCTATCAGCCCATCTGAG, CACG
CACGATGAGCACCTCC (segment H, from RP11-382B18,
AC019322) were used to amplify genomic DNA for cosmid
library screening. PCR products were random primer
labeled with a32P dCTP (specific activity, 1–2106 c.p.m.
per ml hybridization mixture) using the RediprimeII kit
(Amersham Biosciences). LA15NC01, a chromosome 15
cosmid library (www.hgmp.mrc.ac.uk/geneservice) was
screened using Express-hyb buffer (Amersham Biosciences).
Individual positive clones 30H17 (segment H) and 13H18
(segment S) were confirmed by PCR using the original and
additional flanking PCRs (see Figure 1 for locations of all
three probes).
Chromosome studies
Molecular cytogenetic studies were performed on chromo-
somes taken from peripheral blood cells. Chromosome
preparations were obtained according to standard proto-
cols.17 FISH was performed as previously described.18
Cosmid clones were labeled with biotin or digoxygenin
by nick translation (Invitrogen). Biotin was detected with
an avidin-fluorescein isothiocyanate system (green) and
digoxygenin was detected with anti-digoxygenin-rhoda-
mine (red). The yellow signal was obtained by inde-
pendently labeling the BAC clone with biotin and
digoxygenin, which when colocalized give yellow.
Slides were mounted in Vectashield (Vector Laboratories)
containing4,6-diamidino-2-phenylindole as counterstain.
Hybridization signals were visualized and analyzed using
an Isis FISH Imaging System (Metasystems).
Linkage disequilibrium estimates
We calculated r2 estimates of linkage disequilibrium
(LD) between the inversion polymorphism and the 2 bp
Table 1 FISH analysis of CHRFAM7A duplicon
No. of interphases
Sample Ethnicitya Diagnosisb Total Allele 2 Allele 3 CNa Inv genotypeb 2 bp genotypec
109 WC BPD 90 0 21 2 33 33
110 WC/AC BPD 93 0 19 2 33 33
111 WC SZ 50 0 24 1 13 13
117 WC SZ 150 22 8 2 23 23
161 WC P 132 25 6 2 23 23
179 WC SZ 62 15 0 1 12 12
200 A SZ 140 14 0 2 22 22
201 ASA P 76 0 10 1 13 13
205 WC C 121 19 2 2 23 23
211 A P 52 9 10 2 23 23
240 WC P 143 15 20 2 23 33
311 WC C 71 8 8 2 23 23
Abbreviations: A, African; ASA, Afro-South American; BPD, bipolar disorder; C, control; P, psychosis; SZ, schizophrenia; WC, white Caucasian; WC/AC,
mixed race (AC, Afro-Carribbean).
aCHRFAM7A copy number.
bInversion genotype: 1, CHRFAM7A null allele; 2, CHRFAM7A inverted relative to CHRNA7 (as in the database); 3, CHRFAM7A direct orientation.
c2 bp deletion genotype: 1, CHRFAM7A null; 2, CHRFAM7A wt; 3, CHRFAM7A 2bpdel. The genotypes of sample 240 that prevent perfect LD
between the polymorphisms are shown in bold.
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deletion polymorphism using Gene Counting19 and 2LD.20
Because of the occasional presence of the CHRFAM7A null
allele, a few samples were haploid for either polymor-
phism. To overcome this complication, haplotype frequen-
cies for the two polymorphisms were initially estimated for
the diploid samples using Gene Counting. These frequency
estimates were then adjusted to include the haplotypes for
the haploid samples, where the phase is always unambi-
guous. We obtained r2 and standard error estimates from
the adjusted estimated haplotype frequencies using 2LD.
Results
A model for partial duplication of CHRNA7
A map showing the duplication structure of 15q13–q14
for the RP11 individual is shown as structure IIb (Figure 1,
bottom), with CHRNA7 and CHRFAM7A in opposite
orientations. This is a modified version of a map shown
previously.14 Segments that share45 kb with495%
sequence identity (mostly499% identity) are shown in
color, with homologous segments sharing the same letter.
Duplicons associated with the duplication of CHRNA7 run
from segments HS (in blue) to segments RZARQ (in yellow),
where the sequences diverge in segment Q.
To derive a model for the creation of CHRFAM7A, we
considered its likely ancestral structure. The CHRFAM7A
null allele is probably part of a chromosome structure that
predates the creation of CHRFAM7A and may represent a
close approximation to this ancestral structure. Structure Ia
(Figure 1, top) represents our best estimate of the ancestral
human structure for this region, combining our data on
RP11, the CHRFAM7A null allele and chimpanzee sequence
(Supplementary Figure 1). Figure 1 shows a plausible series
of steps whereby the RP11 structure (IIb) might have arisen
from the presumed ancestral structure (Ia). Two key events
in the creation of CHRFAM7A are a 2.1 Mb duplication
followed by a 1.6 Mb deletion, via an intermediate
structure containing two complete copies of CHRNA7. It
is possible, however, that these two steps might have
occurred as a single meiotic event (Supplementary
Figure 2). Whether or not these two steps were combined,
our proposed scheme predicts the existence of structure IIa.
To generate the RP11 structure (IIb) from structure IIa
requires inversion of segments HSRZ, probably by non-
allelic homologous recombination (NAHR) between the
two inverted repeats that flank segments H and S (defining
a 320 kb region). (As presented in Figure 1, 60 kb deletion of
segments AZ is also required, although this might have
occurred at an earlier step.) An important question,
therefore, is whether there is any evidence for structure
IIa as well as the known structure IIb, thereby identifying a
structural polymorphism with CHRFAM7A in either orien-
tation. Because the putative inversion of segments HSRZ
contains only duplicated segments with no junction
unique to either orientation (Figure 1), it is not possible
to investigate its orientation by examination of small
regions, such as by PCR.
Fluorescent labeling and FISH
To determine the orientation of the CHRFAM7A duplicon,
three fluorescent probes, located in segments B, S and H
(shown on structures IIa and IIb in Figure 1), were used.
FISH results were visualized as a string of fluorescent signals
at interphase, with two alternative patterns of the three
probes adjacent to the CHRFAM7A duplicon and red and
green signals only for the distal CHRNA7 duplicon
(Figure 2). Because of the large distance between the two
duplicons (approximately 1.8 Mb) it was only occasionally
possible to observe all five signals together in the same
string (Figure 2a and b). Where two copies of CHRFAM7A
were present, some nuclei showed two strings of signals,
but it was rarely possible to observe more than one
informative string per nucleus in the same focal plane,
such as in Figure 2a. This result clearly demonstrates
that the orientation of CHRFAM7A is polymorphic. A few
experiments were also performed with an alternative
labeling pattern to control for possible labeling artifacts,
but the resulting order of segments was identical (not
shown).
A total of 12 samples were analyzed by careful examina-
tion of a minimum of 50 individual interphases per sample
(Table 1). We determined the orientation of the CHRFAM7A
inversion according to the order of the three signals,
assigning allele 2 to yellow-green-red and allele 3 to yellow-
red-green. We also determined copy number of CHRFAM7A
for each sample, enabling us to identify all three alleles:
allele 1 (CHRFAM7A null) or alleles 2 or 3 (the two
alternative orientations of CHRFAM7A). Alleles 2 and 3
appear to be of similar frequency and all three alleles were
observed in both white Caucasian and black subjects.
Designation of each orientation was initially performed
blind to CHRFAM7A copy number. For the nine samples
with a copy number of 2, we analyzed further interphases
to minimize error, but for sample 200, their quality did not
allow us to interpret more than 14 interphases. For samples
117, 161 and 205 that are apparently heterozygous for
orientation but display a disparity in the two orientations,
we re-examined interphases with the infrequent orienta-
tion to confirm their validity.
The 2 bp deletion polymorphism is a surrogate marker
for the inversion polymorphism
It is possible that due to lack of recombination within the
inversion, genetic isolation of this DNA may have
occurred. To investigate this, all 12 samples were geno-
typed for a polymorphism specific to CHRFAM7A, the 2 bp
deletion polymorphism within exon 6. We genotyped this
polymorphism by a combination of two assays as described
previously16 to identify all three alleles: allele 1 (CHRFA-
M7A null, as above), allele 2 (wt CHRFAM7A), allele 3
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(CHRFAM7A with 2 bp deletion). Comparison of the two
polymorphisms in chromosomes containing CHRFAM7A
(Table 1) revealed strong LD between them (r2¼0.82, CI
0.53–1.00, P¼0.00003), with the 2 bp deletion almost
always occurring when CHRFAM7A is in the same orienta-
tion as CHRNA7. Only sample 240 prevents perfect LD
between the two polymorphisms. In the RP11 individual,
where CHRFAM7A is in the opposite orientation to
CHRNA7,14 the 2 bp deletion is absent in both relevant
BAC clones (RP11-382B18, AC019322; RP11-40J8,
AC010799), which is consistent with this result.
Discussion
We have shown here that the CNV at 15q13–q14, which
includes part of CHRNA7, contains a duplicon that
frequently exists in either orientation and therefore
contains a very common polymorphic inversion. We have
previously reported that this CNV has a null allele
frequency of around 10%.16 Thus, the remaining 90% of
chromosomes containing CHRFAM7A are approximately
equally divided between the two alternative orientations.
The proximal end of chromosome 15 contains many
segmental duplications, which are probably responsible for
some of the genomic rearrangements known to occur in
this region.21,22 In a recent paper we presented a compre-
hensive study of the arrangement of segmental duplica-
tions in the individual whose DNA was used to construct
the RP11 library and responsible for the bulk of sequence
information on the public access human sequence
databases.14 In Figure 1 and the supplementary figures we
propose a plausible way by which the only fully known
structure for this region might have been generated. We
already had evidence for the existence of a chromosome
structure without the CHRFAM7A duplicon and adjacent
duplicon, which could be represented by structures Ia, Ib
and/or Ic in our proposed scheme. We now have evidence
for a structure with the CHRFAM7A duplicon in opposite
orientation to that found in the RP11 individual, which is
consistent with structure IIa. These observations therefore
support the existence of a pathway for the evolution of
15q13–q14, similar to that proposed, and for the persis-
tence of some of the proposed ancestral structures in
present human populations.
We have found that the CHRFAM7A inversion poly-
morphism is in strong LD with the 2 bp deletion poly-
morphism within exon 6 of CHRFAM7A. A similar situation
has arisen with the well-studied 900 kb polymorphic
inversion at 17q21.31, each orientation of which is
Figure 2 Examples of informative interphase chromosomes. (a) A rare example of two informative alleles in the same nucleus: allele 2 (yellow-
green-red, CHRFAM7A inverted with respect to CHRNA7 as in RP11 structure) and allele 3 (yellow-red-green (red-green), CHRFAM7A in same
orientation as CHRNA7), (b) a rare unambiguous example of all five signals on same string: allele 2 (yellow-green-red-red-green), (c) allele 2, (d– f)
allele 3. See Figure 1 for location of probes.
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strongly associated with one of two haplotypes H1
and H2 that appear to have diverged around 3 Myr ago.23
Other studies have described similarly strong patterns
of LD between CNVs and SNPs, where the CNV is ancestral
as evident from the same strong LD in different
ethnicities.24 – 26 Strong LD has also been observed between
other structural variants and SNPs.27 These strong LD
relationships have suggested that these genomic variants
have arisen as single ancestral events on a particular
haplotype background rather than from repeated muta-
tional events. Where it occurs with inversions, such strong
LD is likely to persist for a very long time, due to lack of
recombination within the inversion. The 2 bp deletion is
therefore likely to be part of a haplotype associated with
the CHRFAM7A inversion and supports the notion of an
ancestral relationship between the two alternative orienta-
tions.
Both the 2 bp deletion and the orientation of CHRFAM7A
may have functional consequences. The most likely effect
of the 2 bp deletion would be to disrupt the reading frame
to prevent translation of full-length CHRFAM7A protein.
However, it is unknown whether CHRFAM7A is translated.
Alternatively, CHRFAM7A mRNA may affect CHRNA7
expression by competition for transcription factors. If so,
the inversion could affect expression of CHRFAM7A
mRNA, modulating CHRNA7 expression. One of the
presumed breakpoints of the inversion (indicated above
structure IIa, Figure 1) lies around 25 kb upstream of
CHRFAM7A, possibly altering the location or effect
of regulatory elements. However, for CHRFAM7A gene
products to influence expression of CHRNA7, both genes
must be expressed in the same cell, but, with different
promoter and 50 regions, this is far from certain.
There may be biological consequences of the orientation
of CHRFAM7A that are independent of expression. Some
inversions are known to affect the risk of genomic
rearrangements in meiosis and therefore affect the next
generation. One example is an inversion at 15q11–q13
that is strongly overrepresented in mothers of Angelman
syndrome (AS) patients28 and which we recently reana-
lyzed in light of our improved map of this region of
chromosome 15.14 This and other examples at 4p16, 5q35,
7q11.23, 8p23 and Yp11.2 have been recently reviewed.29
When CHRFAM7A and CHRNA7 are in opposite orienta-
tion, there is likely to be a small increased risk of inv dup
(15) syndrome.30 This syndrome occurs in around 1 in
10 000 live births, with phenotypes including autism and
seizures, and arises from a maternal duplication on a
supernumerary marker chromosome that includes the
critical imprinted region deleted in Prader–Willi and
Angelman syndromes (PWS/AS). More than half of cases
involve NAHR between inverted repeats in 15q13–q14
(breakpoints BP4 and 5, under structure IIb in Figure 1),31
which in the RP11 structure can partly be accounted for by
the inverted relationship between the CHRNA7 and
CHRFAM7A duplicons.14 If NAHR occurred between these
repeats within the same chromatid, an inversion of the
region between BP4 and 5 would occur. Interestingly, a
common polymorphic inversion in 15q13.3 has been
recently reported.32 Although its exact location was not
determined, it is clear from the location of the probes used
that it is not the same as the smaller CHRFAM7A inversion
within BP4 described here and is consistent with inversion
of the region between BP4 and 5. It will be interesting to
know the limits of this inversion and its LD relationship
with the CHRFAM7A inversion.
When CHRFAM7A and CHRNA7 are in the same orienta-
tion, there is likely to be a small increased risk of deletions
or duplications of CHRNA7 and flanking regions. Indivi-
duals with CHRNA7 deletions are likely to be viable as
CHRNA7 null mice are without a major phenotype33 and,
in humans, a small proportion of PWS/AS patients have
large deletions that extend to CHRNA7.34 Individuals with
CHRNA7 duplications would also be expected to be viable
as patients with inv dup (15) syndrome often have three
copies of CHRNA7 as do largely asymptomatic subjects
with the equivalent paternal duplications.31 Our 2 bp
deletion data suggest infrequent CHRNA7 deletions
(o0.6%), as our assay would have detected such a
deletion in patients homozygous for the 2 bp deletion in
CHRFAM7A.16 Other copy number studies have indicated a
higher frequency of deletions/duplications of CHRNA7
(1135 and 20%,36 mainly due to deletions), but most of
these appear to be much smaller deletions/duplications
than BP4–5. However, in a recent study of about 2000
mental retardation cases, nine individuals (six unrelated)
were identified with BP4–5 deletions and had pheno-
types that also included seizures, abnormal EEG and/or
dysmorphic features.32 When around 1000 controls were
investigated in the same study, one BP4–5 duplication was
detected but no similar deletions. It was suggested that
these rare deletions and duplications of BP4–5 might
be linked to the large BP4–5 inversion. Whether such a
link is established, our data strongly suggest a link with the
smaller CHRFAM7A inversion involving NAHR between
CHRNA7 and CHRFAM7A duplicons when in direct
orientation.
Because of the strong LD between them, the 2 bp
deletion polymorphism can be used as a surrogate for the
CHRFAM7A inversion polymorphism. We can therefore
reassess previous studies involving the 2 bp deletion
polymorphism. A French study reported an association
between the 2 bp deletion and abnormal P50.37 A more
recent study reported association between the 2 bp deletion
and poor episodic memory, another endophenotype
of schizophrenia.38 It is therefore possible that the
CHRFAM7A inversion is associated with some endopheno-
types of schizophrenia. In our earlier study, we found no
association of the 2 bp deletion with schizophrenia, bipolar
disorder or psychosis, although we did find an association
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between heterozygotes for the CHRFAM7A null allele and
psychosis.16 The same French group described above also
failed to find association of the 2 bp deletion with
schizophrenia.37 A Chinese group investigating the 2 bp
deletion polymorphism without considering the CHRFA-
M7A CNV reported no association with schizophrenia39
but found association of the 2 bp deletion with bipolar
disorder.40 These differences may be due to greater
statistical power required to detect association with
genetically more complex phenotypes compared to endo-
phenotypes. Such a pattern was seen with the CHRNA7
region of 15q13–q14, which showed strong linkage to the
P50 endophenotype but only weak linkage to schizo-
phrenia within the same study.1
We have shown that, where present, CHRFAM7A exists
in either orientation. It therefore appears that at least
two versions of this region of 15q13–q14 ancestral to the
version presented in the database have persisted at a
significant frequency. It remains to be determined whether
any of these common genomic variants is involved in
psychosis. Such important genetic studies have been made
feasible by our observation that the CHRFAM7A inversion
polymorphism is in strong LD with the 2 bp deletion
polymorphism in exon 6 of CHRFAM7A as the latter, which
is more practical than FISH for large-scale genotyping,
can therefore be used as a surrogate marker. We plan
to investigate association of these variants with P50 and
other endophenotypes of schizophrenia in a large sample
of psychosis patients and their unaffected relatives.
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